Organophosphate Flame-Retardant Metabolite Concentrations and Pregnancy Loss Among Women Conceiving with Assisted Reproductive Technology
-
2018/11/01
-
Details
-
Personal Author:Butt CM ; Carignan CC ; Ford JB ; Hauser R ; Meeker JD ; Messerlian C ; Mínguez-Alarcón L ; Souter I ; Stapleton HM ; Williams PL
-
Corporate Authors:
-
Description:Objective: To evaluate whether urinary concentrations of organophosphate flame retardant (PFR) metabolites are associated with pregnancy loss among women conceiving with assisted reproductive technology (ART). Design Prospective preconception cohort of subfertile women. Setting: Academic hospital fertility center in Boston, Massachusetts. Patient(s): A total of 155 women conceiving 179 pregnancies with ART. Intervention(s): None. Mean exposure to each of five PFR metabolites was estimated by averaging the specific-gravity adjusted natural log concentrations from two urine samples collected during the ART cycle of conception. Main Outcome Measure(s): Adjusted risk ratios (RRs) and 95% confidence intervals (CIs) for biochemical and total pregnancy loss (all losses <20 weeks' gestation) by quartiles of PFR metabolite concentrations were estimated using a repeated measures log-binomial model, accounting for multiple pregnancies per woman. Result(s): Of the 179 pregnancies, 31% ended in pregnancy loss (12% in biochemical loss). Among the three metabolites with high detection frequency [bis(1,3-dichloro-2-propyl) phosphate (BDCIPP), diphenyl phosphate (DPHP), and isopropylphenyl phenyl phosphate (ip-PPP)], an increased risk of biochemical loss was observed for women with DPHP concentrations in the fourth vs. first quartile (RR 1.64; 95% CI 0.61-4.39). Also found was an elevated risk of biochemical pregnancy loss among women in the highest quartile of the molar sum of urinary PFR metabolites compared with the lowest (RR 1.89; 95% CI 0.64-5.58). Urinary concentrations of ip-PPP and BDCIPP were not associated with either outcome. Conclusion(s): Among subfertile women, urinary DPHP metabolite concentrations measured during the ART cycle of conception may be associated with early pregnancy loss. Although this study is uniquely designed to investigate early markers of pregnancy success and maintenance, the small sample size likely contributed to imprecision. Given their increasing use as replacement chemicals for traditional flame retardants, exposure to PFRs may increase, and more studies will be needed to investigate their potential to impact pregnancy and reproduction. Main Outcome Measure(s): Adjusted risk ratios (RRs) and 95% confidence intervals (CIs) for biochemical and total pregnancy loss (all losses <20 weeks' gestation) by quartiles of PFR metabolite concentrations were estimated using a repeated measures log-binomial model, accounting for multiple pregnancies per woman. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0015-0282
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:110
-
Issue:8
-
NIOSHTIC Number:nn:20055578
-
Citation:Fertil Steril 2018 Nov; 110(8):1137-1141.e
-
Contact Point Address:Carmen Messerlian, Ph.D., Harvard T.H. Chan School of Public Health, Department of Environmental Health, 665 Huntington Avenue, FXB-102A, Boston, Massachusetts 02115
-
Email:cmesser@hsph.harvard.edu
-
Federal Fiscal Year:2019
-
Performing Organization:University of Michigan, Ann Arbor
-
Peer Reviewed:True
-
Start Date:20050701
-
Source Full Name:Fertility and Sterility
-
End Date:20280630
-
Collection(s):
-
Main Document Checksum:urn:sha-512:2a7776a9980477b3a07efeff5a57d8de35e392396bff1f56c254a0ab608a7417e9024f16b619ae316fa262ee3147343810137d3ed88431c1242cfada3199f3aa
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like